Trials / Completed
CompletedNCT04813679
Bed-side Ultrasound in Neutropenic Enterocolitis
Bed-side Ultrasound in the Evaluation of Gastro-intestinal Tract and Neutropenic Enterocolitis (NEC) in Neutropenic Patients.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,740 (actual)
- Sponsor
- Azienda Ospedaliero, Universitaria Pisana · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Neutropenic enterocolitis (NEC) is a life-threatening complication of leukemic and solid tumors patients (pts) treated with chemotherapy (CHT) with high mortality rate up to 50-100%. Perforation occurs in 5%-10% of cases. Early diagnosis is crucial to start conservative medical management (CMM), which appears the optimal strategy for most cases. NEC should be always suspected in Neutropenic pts with abdominal pain, fever and diarrhea. Ultrasound (US) can be used to evaluate bowel-wall thickening (BWT). The objective of this study is to evaluate prospectively if US can detect early signs of NEC and guide a prompt treatment (CMM or surgical) and thus reduce mortality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Bed side Ultrasound Sonography | Bed side Ultrasound in Neutropenic patients within 12 h from onset of any symptom such as fever and/or abdominal pain and/or diarreha |
Timeline
- Start date
- 2007-03-01
- Primary completion
- 2018-01-01
- Completion
- 2018-01-01
- First posted
- 2021-03-24
- Last updated
- 2021-03-24
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04813679. Inclusion in this directory is not an endorsement.